Pricing
  1. US-listed companies
  2. INVO Fertility, Inc.
  3. Raw

INVO Fertility, Inc.【IVF】

Market cap
$214.91K
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net loss-4,959,247-2,124,252-702,163-3,076,091-2,167,544-8,347,316-6,654,940-10,892,511-8,034,612-9
Non-cash stock compensation issued for services91,318--246,000150,862--287,4501
Non-cash stock compensation issued to directors and/or employees----17,750465,140360,153484,80756,936153
Fair value of stock options issued to employees--------1342,728
Non-cash compensation for services-------120,000180,000180,000
Amortization of discount on notes payable-1215,132366,126337,4132152,644720,128622,283
Reserve on other assets---------498,592
Gain (loss) from equity method joint ventures---------60,2709,045
Impairment from equity method joint ventures---------89,794-
Loss from debt extinguishment-4,332,155--40,869--93,750-159,126--163,278-40,491
Loss on disposal of fixed assets----------511,663
Gain on lease termination---------94,551
Depreciation and amortization5,6331,8782,8105,19010,78811,91727,76077,301200,894919,603
Accounts receivable---139,202-218,34114,14128,77126,67963,40134,331
Inventory2,96519,790-26,331-15,36657,874163,98522,401-905-44,743
Prepaid expenses and other current assets-10,98052,070-200,596-53,544-38,210124,811-92,550432,093163,761
Equity investments----------4,534
Accounts payable and accrued expenses----377,814-200,298-42,603114,495904,060924,6781
Accrued compensation388,800486,000378,800241,299-1,410,077134,30954,363364,573-224,011274,665
Deferred revenue---18,8954-714,286-3,565,529113,976288,893193,590
Other current liabilities---------226,568-
Leasehold liability--------221,99285,19125,869
Accrued interest------20,9211,556121,864166,772
Deferred tax liabilities----433--810-1,949-
Net cash used in operating activities-151,622-323,900-181,270-652,9711-4,775,148-6,029,914-6,603,319-4,755,054-2,974,400
Payments to acquire property, plant, and equipment-15,700-19,40064,83949,261415,71010,785444,722183,703
Proceeds from sale of fixed assets---------75,590
Cash acquired in acquisition---------472,008
Investment in joint ventures-----98,084----
Payment for acquisitions--------2-
Net cash used in investing activities--15,700--19,400-114,706-187,254-2,153,512-81,217-2,494,879363,895
Proceeds from notes payable-----3-100,00031
Proceeds from notes payable – related parties-------700,000100,000-
Proceeds from the sale of common stock, net of offering costs645,000-54,62547,000-114060
Proceeds from the sale of preferred stock---------2
Proceeds from warrant exercise------123,562-23,051900,611
Proceeds from option exercise--------2,375-
Principal payments on notes payable----131,722770,000250,000-1934,419
Net cash provided by financing activities625,000-54,625858,855-229,465144173
Increase in cash and cash equivalents-------4,412,889-5,594,736142,289508,972
Interest------52,603-9,640214,742
Taxes------3,307800--
Fair value of preferred stock issued for acquisition ---------25
Common stock issued upon conversion notes payable and accrued interest---------387,033
Deemed dividend---------250,635
Fair value of warrants issued with debt--------490,668188,755
Fair value of common stock issued with debt--------56,314-
Fair value of shares issued for settlement of liability---387,000-8,660--65,198-
Initial ROU asset and lease liability--------4-
Fair value of Series B preferred shares issued in exchange for shares of NAYA common stock--------2-